Form 4 for ALAB Astera Labs, Inc.
Accepted 2024-10-04 00:00:00 ET · period of report 2024-10-02 · accession 0001736297-24-000035 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-10-04 | 2024-10-02 | ALAB | Tate Michael Truett | CFO | G - Gift | $0.00 | -1.03M | 293.1K | -78% | $0 | |
| I | 2024-10-04 | 2024-10-02 | ALAB | Tate Michael Truett | CFO | G - Gift | $0.00 | +1.03M | 1.86M | +125% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-10-02 | G | D | 1,033,780 | $0.00 | 293,128 | D By Tate Trust | — | — | (F2) These shares are owned directly by the Tate Trust, of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. |
| 2 | Common | Common Stock | 2024-10-02 | G | A | 1,033,780 | $0.00 | 1,862,888 | I | — | — |